Amfenac Sodium Monohydrate

CAS No. 61618-27-7

Amfenac Sodium Monohydrate( Amfenac sodium H2O )

Catalog No. M15326 CAS No. 61618-27-7

Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 41 Get Quote
50MG 50 Get Quote
100MG 72 Get Quote
200MG 106 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Amfenac Sodium Monohydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety.
  • Description
    Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety.(In Vitro):Cells transfected to express COX-2 have a higher proliferation rate than those do not. The addition of Amfenac Sodium Hydrate significantly decreases the proliferation rate of all cell lines. Nitric oxide production by macrophages is inhibited by the addition of melanoma conditioned medium, the addition of Amfenac Sodium Hydrate partially overcomes this inhibition. Results show that Amfenac Sodium Hydrate inhibits the release of B-glucuronidase: 5×10-4 M Amfenac Sodium Hydrate inhibits the release of the enzyme 35.3 and 16.3% in the presence of 10-8, and 10-7 M FMLP, respectively. Addition of 10-4 M Amfenac Sodium Hydrate causes 28.3% inhibition of aggregation of polgmorphonuclear leukocgtes (PMNs) during incubation for 16 min with 10-8 M FMLP.
  • In Vitro
    Cells transfected to express COX-2 have a higher proliferation rate than those do not. The addition of Amfenac Sodium Hydrate significantly decreases the proliferation rate of all cell lines. Nitric oxide production by macrophages is inhibited by the addition of melanoma conditioned medium, the addition of Amfenac Sodium Hydrate partially overcomes this inhibition. Results show that Amfenac Sodium Hydrate inhibits the release of B-glucuronidase: 5×10-4 M Amfenac Sodium Hydrate inhibits the release of the enzyme 35.3 and 16.3% in the presence of 10-8, and 10-7 M FMLP, respectively. Addition of 10-4 M Amfenac Sodium Hydrate causes 28.3% inhibition of aggregation of polgmorphonuclear leukocgtes (PMNs) during incubation for 16 min with 10-8 M FMLP.
  • In Vivo
    ——
  • Synonyms
    Amfenac sodium H2O
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-1| COX-2
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    61618-27-7
  • Formula Weight
    295.27
  • Molecular Formula
    C15H12NO3·H2O·Na
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 4 mg/mL (13.54 mM); Water: 59 mg/mL (199.81 mM); DMSO: 59 mg/mL (199.81 mM)
  • SMILES
    O=C([O-])CC1=CC=CC(C(C2=CC=CC=C2)=O)=C1N.[H]O[H].[Na+]
  • Chemical Name
    Benzeneacetic acid, 2-amino-3-benzoyl-, sodium salt, monohydrate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gamache DA, et al. Inflammation, 2000, 24(4), 357-370.
molnova catalog
related products
  • Phenacetin

    Phenacetin is a non-opioid analgesic without anti-inflammatory properties. Its analgesic effects are due to its actions on the sensory tracts of the spinal cord.

  • Nitroflurbiprofen

    Nitroflurbiprofen is a NO-releasing COX inhibitor and modulates the increased intrahepatic vascular tone in portal hypertensive cirrhotic rats.

  • 4-Cyclohexyl-1-pheny...

    4-Cyclohexyl-1-phenylthiosemicarbazide